8-K: Rimini Street Faces Nasdaq Delisting Notice Due to Audit Committee Vacancy

Rimini Street has received a notification from Nasdaq regarding non-compliance with audit committee requirements due to a recent board resignation.

Summary

• Rimini Street received a letter from Nasdaq on September 5, 2024, stating they are not compliant with Nasdaq Listing Rule 5605 regarding audit committee composition.
• The rule requires at least three independent members on the audit committee.
• The non-compliance is due to the resignation of Ms. Katrinka McCallum on August 2, 2024, leaving only two qualified directors on the committee.
• Nasdaq has provided a cure period for Rimini Street to regain compliance.
• The cure period extends until the earlier of the next annual meeting or August 2, 2025.
• If the next annual meeting is before January 29, 2025, compliance must be achieved by January 29, 2025.
• Rimini Street intends to fill the vacancy and regain compliance within the given timeframe.

Sentiment

Score: 3

Explanation: The document indicates a compliance issue, which is a negative development for the company. However, a cure period has been granted, which mitigates some of the immediate risk.

Positives

• Nasdaq has provided a cure period for Rimini Street to regain compliance.
• Rimini Street intends to fill the audit committee vacancy and regain compliance within the cure period.

Negatives

• Rimini Street is currently not compliant with Nasdaq's audit committee requirements.
• The company's audit committee is currently understaffed with only two members.

Risks

• Failure to regain compliance within the cure period could lead to delisting from the Nasdaq.
• The lack of a fully compliant audit committee could raise concerns about corporate governance.

Future Outlook

Rimini Street intends to fill the audit committee vacancy and regain compliance with Nasdaq listing rules within the provided cure period.

Management Comments

• Rimini Street intends to fill the vacancy on the Audit Committee and regain compliance with the audit committee composition requirements under Nasdaq Listing Rule 5605 before the end of the cure period described above.

Industry Context

This announcement highlights the importance of maintaining proper corporate governance and compliance with exchange listing rules, which is a common concern for publicly traded companies.

Comparison to Industry Standards

• Nasdaq Listing Rule 5605 is a standard requirement for all companies listed on the Nasdaq, ensuring a minimum level of independent oversight.
• Many companies, such as Oracle and SAP, also have similar audit committee structures to ensure compliance and good governance.
• Failure to meet these standards can lead to delisting, which has happened to other companies in the past, such as China-based companies that failed to meet US audit standards.

Stakeholder Impact

• Shareholders may be concerned about the potential for delisting.
• Employees may be concerned about the company's stability.
• Creditors may be concerned about the company's compliance with listing rules.

Next Steps

• Rimini Street needs to appoint a new independent director to the audit committee.
• The company must notify Nasdaq of its compliance with the listing rule within the cure period.

Key Dates

Keywords

Nasdaq, audit committee, compliance, delisting, corporate governance, Rimini Street, board of directors